(Q37774965)

23 August 2017

1 reference

title

Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review (English)

1 reference

head and neck squamous cell carcinoma

23 August 2017

1 reference

1 reference

inferred from title

adenoid cystic carcinoma

1 reference

7

Jochen A Werner

1 reference

23 August 2017

3

Alessandra Rinaldo

1 reference

23 August 2017

8

Alfio Ferlito

1 reference

23 August 2017

5

Robert P Takes

1 reference

23 August 2017

Giorgos Papaspyrou

1

1 reference

23 August 2017

Stephan Hoch

series ordinal

2

1 reference

23 August 2017

Juan P Rodrigo

series ordinal

4

1 reference

23 August 2017

Carla van Herpen

series ordinal

6

1 reference

23 August 2017

publication date

22 July 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

33

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

905-911

1 reference

Adenoid cystic carcinoma of the head and neck: a review

23 August 2017

cites work

1 reference

Glandular tumors of the external auditory canal

21 January 2018

1 reference

Adenoid cystic carcinoma of the nasopharynx: 27-year experience.

21 January 2018

1 reference

Adenoid cystic carcinoma of the larynx: a 40-year experience.

21 January 2018

1 reference

Oesophageal adenoid cystic carcinoma and its management options

21 January 2018

1 reference

Adenoid cystic breast carcinoma: high rates of margin positivity after breast conserving surgery

21 January 2018

1 reference

Adenoid cystic carcinoma of the trachea treated with PET-CT based intensity modulated radiotherapy

21 January 2018

1 reference

Adenoid cystic carcinoma.Biologic behavior in 38 patients

21 January 2018

1 reference

Stage means more than grade in adenoid cystic carcinoma

21 January 2018

1 reference

Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up

21 January 2018

1 reference

Adenoid cystic carcinoma of the salivary glands: a review of 10 years

21 January 2018

1 reference

Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality.

21 January 2018

1 reference

Survival from salivary glands adenoid cystic carcinoma in European populations

21 January 2018

1 reference

Facial nerve sacrifice and radiotherapy in parotid adenoid cystic carcinoma

21 January 2018

1 reference

[Adenoid cystic carcinoma of the oropharynx. Brachytherapy for the treatment of local recurrences].

21 January 2018

1 reference

Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.

21 January 2018

1 reference

Chemotherapy for salivary gland cancer

21 January 2018

1 reference

Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients

21 January 2018

1 reference

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group

21 January 2018

1 reference

Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies.

21 January 2018

1 reference

Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).

21 January 2018

1 reference

Chemotherapy of malignant major salivary gland neoplasms.A 25-year review of M.D. Anderson hospital experience

21 January 2018

1 reference

Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin:A case report with a review of the literature

21 January 2018

1 reference

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

21 January 2018

1 reference

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

21 January 2018

1 reference

Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland

21 January 2018

1 reference

Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer

21 January 2018

1 reference

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).

21 January 2018

1 reference

Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.

21 January 2018

1 reference

Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases

21 January 2018

1 reference

Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases

21 January 2018

1 reference

7 January 2021

Epithelial tumors of the lacrimal gland. A comparison of the pathologic and clinical behavior with those of the salivary glands

1 reference

7 January 2021

Adenoid Cystic Carcinoma of the Nose, Paranasal Sinuses, and Palate

1 reference

7 January 2021

Adenoid cystic carcinoma of the uterine cervix

1 reference

7 January 2021

Adenoid cystic carcinoma in the head and neck (cylindroma)

1 reference

7 January 2021

Reflections on the management of adenoid cystic carcinoma of the nasal cavity and paranasal sinuses

1 reference

7 January 2021

Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy

1 reference

7 January 2021

Outcomes and Prognostic Variables in Adenoid Cystic Carcinoma of the Head and Neck: A Recent Experience

1 reference

7 January 2021

[Prognostic factors in adenoid cystic carcinoma of salivary glands]

1 reference

7 January 2021

Radiation therapy in adenoid-cystic carcinoma

1 reference

7 January 2021

Proton beam radiation therapy for skull base adenoid cystic carcinoma

1 reference

7 January 2021

Chemotherapy for adenocystic carcinoma

1 reference

7 January 2021

Cisplatin therapy for adenoid cystic carcinoma

1 reference

7 January 2021

Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck

1 reference

7 January 2021

Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck

1 reference

7 January 2021

Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group

1 reference

7 January 2021

Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients

1 reference

7 January 2021

Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma

1 reference

7 January 2021

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

1 reference

7 January 2021

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer

1 reference

7 January 2021

Preliminary experience with chemotherapy in advanced salivary gland neoplasms

1 reference

7 January 2021

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma

1 reference

7 January 2021

Adenoid cystic carcinoma of the salivary gland: Sustained complete response to chemotherapy

1 reference

7 January 2021

5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck

1 reference

7 January 2021

A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands

1 reference

7 January 2021

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

7 January 2021

Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma

1 reference

7 January 2021

Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin

1 reference

7 January 2021

The response of adenoid cystic carcinoma to tamoxifen

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21458

1 reference

23 August 2017

1 reference